News GeneThera, Inc.

Equities

GTHR

US37185E3062

Market Closed - OTC Markets Other stock markets 18:14:13 20/02/2024 GMT			5-day change	1st Jan Change
0.000001 ^USD	-99.98%		-.--%	-.--%

2022	GeneThera, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
2022	GeneThera, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

GENETHERA INC - 10-K/A -	01/02/23	AQ
GENETHERA INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	14/11/22	AQ
GeneThera, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
GENETHERA INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	18/08/22	AQ
GeneThera, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	18/08/22	CI
GENETHERA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	18/05/22	AQ
GeneThera, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	18/05/22	CI
GENETHERA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	14/04/22	AQ
GeneThera, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	14/04/22	CI
GeneThera, Inc. Auditor Raises 'Going Concern' Doubt	13/04/22	CI
GENETHERA INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	15/11/21	AQ
GeneThera, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21	CI
GeneThera : Inc. Enters into an exclusive real estate agreement with Cushman & Wakefield related to the ZIDAS project	12/10/21	GL
GeneThera Inc. Enters into an exclusive real estate agreement with Cushman & Wakefield related to the ZIDAS project	12/10/21	CI
GENETHERA INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	12/10/21	AQ
GENETHERA INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	16/08/21	AQ
Genethera, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	16/08/21	CI
GeneThera : Expands Its Operation in the United Kingdom	18/05/21	AQ
GeneThera, Inc. announced a financing transaction	17/05/21	CI
GENETHERA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	12/05/21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News GeneThera, Inc.

Equities

GTHR

US37185E3062

Summary

Filters